Cargando…
Debating Frontline Therapy in Chronic Myeloid Leukemia
Autores principales: | Bi, Xia, Ramanathan, Sabarina, Keiffer, Gina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456000/ https://www.ncbi.nlm.nih.gov/pubmed/34568035 http://dx.doi.org/10.3389/fonc.2021.708823 |
Ejemplares similares
-
Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China
por: Cheng, Fang, et al.
Publicado: (2023) -
B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemia
por: Wilde, Lindsay, et al.
Publicado: (2020) -
Nilotinib for the Frontline Treatment of Chronic Myeloid Leukemia Carrying the p230 Transcript: Dream or Reality?
por: Capuozzo, Maurizio, et al.
Publicado: (2014) -
The interplay of FLT3 and CXCR4 in acute myeloid leukemia: an ongoing debate
por: Klement, Laura, et al.
Publicado: (2023) -
Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
por: DeRemer, David L, et al.
Publicado: (2011)